Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Franklin Berger Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Kezar Life Sciences, Inc. (Director · Since at least Jun 25, 2019); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Five Prime Therapeutics Inc (Director · Jun 10, 2019 – Apr 16, 2021 · Past); Tocagen Inc (Director · May 29, 2019 – Oct 4, 2019 · Past); Immune Design Corp (Director · Apr 2, 2019 – Apr 2, 2019 · Past) | Director · Since at least Oct 29, 2020 |
| Andrew A F Hack Other companies: Mersana Therapeutics Inc (Director · Since at least Jun 27, 2017); Nuvalent, Inc. (Director · Jul 28, 2021 – Dec 11, 2024 · Past); BCLS Acquisition Corp (Chief Financial Officer, Director · Oct 21, 2020 – Oct 26, 2020 · Past); Dynavax Technologies Corporation (Director · Aug 12, 2019 – Aug 8, 2023 · Past); Allena Pharmaceuticals Inc (Director · Jun 8, 2018 – Nov 17, 2020 · Past); Editas Medicine, Inc. (Chief Financial Officer · Feb 2, 2016 – Feb 4, 2019 · Past) | Director · Oct 29, 2020 – Nov 3, 2020 · Past |
| Arthur Kirsch Other companies: Evommune, Inc. (Audit · Since at least Nov 5, 2025); Liquidia Corporation (Board Member · Since at least Mar 24, 2021); Kadmon Holdings Inc (Director · May 15, 2019 – Nov 9, 2021 · Past); Aralez Pharmaceuticals Inc (Director · May 12, 2016 – Dec 8, 2017 · Past) | Director · Since at least Feb 20, 2025 |
| Barbara Duncan Other companies: Halozyme Therapeutics, Inc. (Director · Since at least Apr 25, 2024); Ovid Therapeutics Inc. (Director · Since at least Feb 22, 2024); Fusion Pharmaceuticals Inc (Director · Jun 4, 2024 – Jun 4, 2024 · Past) | Director · Since at least Jun 16, 2024 |
| Jean-Pierre Sommadossi Other companies: ABG Acquisition I Corp (Director · Feb 16, 2021 – Mar 1, 2023 · Past); Kezar Life Sciences, Inc. (Director · Jun 20, 2018 – Jun 28, 2021 · Past); Idenix Pharmaceuticals Inc (President, CEO, Chairman, Director · Dec 31, 2005 – Feb 10, 2010 · Past) | Chairman & CEO, Atea Pharmaceuticals · Since at least Oct 29, 2020 |
| Bruce Polsky Other companies: Cogentix Medical Inc (Director · Jul 26, 2012 – Aug 26, 2013 · Past) | Director · Since at least Oct 29, 2020 |
| Howard Berman Other companies: Coya Therapeutics, Inc. (Executive Chairman, Director · Since at least Dec 28, 2022) | Director · Since at least Apr 17, 2025 |
| Polly A. Murphy Other companies: Celcuity Inc. (Director · Since at least Jun 24, 2024) | Director · Since at least Mar 26, 2025 |
| Wayne Foster Other companies: Mersana Therapeutics Inc (Vice President of Finance · Jun 27, 2017 – Jan 23, 2019 · Past) | EXECUTIVE VP, Chief Accounting Officer · Since at least Oct 29, 2020 |
| Adam DeZure | Senior VP, Clinical Development · Since at least Nov 5, 2026 |
| Adel Moussa | EXECUTIVE VP, CHEMISTRY · Since at least Nov 5, 2026 |
| Andrea Corcoran | CFO & Executive VP, Legal · Since at least Oct 29, 2020 |
| Arantxa Horga | Chief Medical Officer · Since at least Mar 26, 2025 |
| Atea Pharmaceuticals | website at ir.ateapharma.com · Since at least Aug 5, 2026 |
| Brian Rowe | VP, Business Development · Since at least Nov 5, 2026 |
| Bruce Belanger | Senior VP, Biostatistics · Since at least Nov 5, 2026 |
| Bruno Lucidi | Director · Since at least Oct 29, 2020 |
| James MB Evans | SENIOR VP, CMC Manufacturing · Since at least Nov 5, 2026 |
| Janet Hammond | CHIEF DEVELOPMENT OFFICER · Since at least Oct 29, 2020 |
| Jayanthi Wolf | Executive VP, Regulatory Affairs · Since at least Nov 5, 2026 |
| Jerome M Adams | Director · Since at least Jun 20, 2025 |
| John Vavricka | Chief Commercial Officer · Since at least Oct 29, 2020 |
| Jonae Barnes | Senior VP, Investor Relations & Corporate Communications · Since at least Nov 2, 2026 |
| Jonae BarnesSVP | Investor Relations and Corporate · Since at least Jul 28, 2026 |
| Keith Pietropaolo | Executive VP, Clinical Sciences and Project Management · Since at least Nov 5, 2026 |
| Laura Ishak | Senior VP, Clinical Operations · Since at least Nov 5, 2026 |
| Marc Van Hulle | VP, Finance · Since at least Nov 5, 2026 |
| Maria Arantxa Horga | Chief Medical Officer · Since at least Jan 31, 2023 |
| Nancy Agrawal | Executive VP, Preclinical Development · Since at least Nov 5, 2026 |
| Qi Huang | Senior VP, Virology · Since at least May 13, 2026 |
| Shari Noble | VP, Deputy General Counsel · Since at least Nov 5, 2026 |
| Xiao-Jian Zhou | EXECUTIVE VP, EARLY STAGE DEVELOPMENT · Since at least May 13, 2026 |